NCT07565584Not yet recruiting
Examining Migration, Social Bonds, Transnationalism, and HIV Prevention Pathways Among African Immigrants.
Migration, Social Bonds, Transnationalism, and HIV Prevention Pathways Among African Immigrants (MiST-Pathways)
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
The goal of this mixed-methods pilot study is to learn whether migration experiences, social bonds, and transnational ties shape HIV prevention decision-making, including HIV testing, HIV self-testing (HIVST), and pre-exposure prophylaxis (PrEP) uptake, among first-generation African immigrants aged 18 to 50 residing in New York and Massachusetts. The main questions it aims to answer are: * What relationship typologies and migration-related relational mechanisms influence HIV testing, HIVST, and PrEP decision-making among African immigrants? * Can a relationship-tailored HIV prevention intervention component, co-developed with the community, demonstrate feasibility and acceptability among African immigrants? * Does exposure to the prioritized intervention component show directional increases in HIV testing intention, willingness to use HIVST, interest in PrEP, and readiness for relationship-based prevention communication? There is no comparison group. All Aim 3 participants receive the same co-developed intervention component. Participants will: * Complete a qualitative interview (60-90 minutes) and/or a structured electronic survey (15-20 minutes) about their relationship experiences, migration history, and HIV prevention behaviors. * Take part in a 3-4 hour structured group deliberation session called a Palava Hut Conversation to co-develop and prioritize HIV prevention intervention ideas. * Complete a baseline survey, receive the prioritized intervention component in a structured Zoom session, and complete a follow-up survey with an optional 60-90 minute cognitive interview for a subset of participants.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 144 (estimated)
- First submitted
- 27 Apr 2026
- Start date
- 4 Dec 2026
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- State University of New York at Buffalo
- Diseases
- HIV
- NCT number
- NCT07565584
What you commit to
- Study type: Interventional
- Planned participants: 144
- From 4 Dec 2026 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Are under 18 years of age
Other
- Do not self-identify as a first-generation African immigrant
- Do not reside in New York or Massachusetts
- Are unable to provide informed consent
- Do not have access to the technology required for virtual participation (Zoom and/or WhatsApp)
Who the study is looking for
- Age 18 to 50 years at the time of enrollment
- Self-identify as a first-generation African immigrant (born in an African country and currently residing in the United States)
- Currently reside in New York or Massachusetts
- Able to communicate in English at approximately a 3rd-grade reading level
- Have access to a smartphone or computer with internet capability sufficient to participate in Zoom and/or WhatsApp-based study activities
- Willing and able to provide informed consent
Age in the registry: 18 years to 50 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| State University of New York at Buffalo Coordinator of this site? Confirm its status | Buffalo | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.